Soleus Capital Master Fund, L.P.

Holdings History for C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Symbol
CCCC on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
10,361,860 shares
Security Ownership %
10%

Soleus Capital Master Fund, L.P. ownership in C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

12 Feb 2026 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,361,860 shares of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC). This represents 10% ownership of the company. This is the first filing by Soleus Capital Master Fund, L.P. disclosing ownership of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC).